Yangnong Chemical(SH:600486)2023-04-24 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥4,500,001,753.05, a decrease of 14.57% compared to the same period last year[4] - Net profit attributable to shareholders was ¥754,275,388.01, down 16.59% year-on-year[4] - The basic earnings per share for the period was ¥2.434, a decrease of 16.59% compared to the previous year[4] - Total operating revenue for Q1 2023 was ¥4,500,001,753.05, a decrease of 14.6% compared to ¥5,267,778,294.74 in Q1 2022[21] - Net profit for Q1 2023 was ¥754,527,453.92, a decline of 16.6% from ¥904,504,399.84 in Q1 2022[23] - Total comprehensive income for Q1 2023 was ¥757,417242.61, down 15.6% from ¥897,358,047.90 in Q1 2022[23] Cash Flow - The net cash flow from operating activities increased by 92.70% to ¥1,521,076,742.64[4] - Cash flow from operating activities increased to ¥1,521,076,742.64, up 92.9% from ¥789,353,356.17 in Q1 2022[25] - The net cash flow from investment activities was -194,830,300.92 CNY, compared to -214,321,080.74 CNY in the previous period, indicating a slight improvement[26] - Cash inflow from financing activities totaled 250,000,271.20 CNY, significantly higher than 96,158,291.94 CNY in the previous period[26] - The net cash flow from financing activities was -6,941,770.17 CNY, a decrease from 33,946,929.63 CNY in the previous period[26] - The cash and cash equivalents at the end of the period amounted to 3,482,180,208.21 CNY, up from 2,516,874,982.41 CNY in the previous period[26] - The total cash and cash equivalents increased by 1,320,627,443.37 CNY compared to an increase of 610,836,752.39 CNY in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period reached ¥15,233,593,313.28, reflecting a 2.98% increase from the end of the previous year[5] - The company's total equity increased to CNY 9,297,668,244.98 from CNY 8,539,455,345.74, reflecting a growth of about 8.86%[20] - Total current liabilities decreased to CNY 5,441,411,516.37 from CNY 5,761,277,121.56, a reduction of approximately 5.56%[17] - The total liabilities decreased to CNY 5,935,925,068.30 from CNY 6,254,008,274.07, a reduction of approximately 5.08%[19] Shareholder Information - The company reported a total of 20,091 common shareholders at the end of the reporting period[10] Inventory and Receivables - Inventory decreased by 38.84% due to strong sales during the reporting period[7] - Accounts receivable increased to CNY 3,108,594,710.41 from CNY 2,664,648,349.62, representing a growth of approximately 16.67%[16] - Inventory decreased significantly to CNY 1,274,938,719.86 from CNY 2,084,484,094.47, a decline of about 38.7%[16] Expenses - Total operating costs decreased to ¥3,619,430,747.12, down 12.0% from ¥4,113,238,804.54 in the same period last year[21] - Research and development expenses for Q1 2023 were ¥117,572,096.81, a slight decrease of 4.0% from ¥122,876,987.97 in Q1 2022[21] - Sales expenses decreased significantly to ¥51,325,045.91, down 41.0% from ¥86,963,442.68 in the previous year[21] - Management expenses decreased to ¥163,729,457.35, down 12.8% from ¥187,648,644.90 in Q1 2022[21] Other Financial Metrics - The weighted average return on equity decreased by 3.77 percentage points to 8.46%[4] - Other comprehensive income after tax for Q1 2023 was ¥2,889,788.69, compared to a loss of ¥7,146,351.94 in Q1 2022[23] Borrowings - Short-term borrowings increased by 83.97% as a result of new bank loans[7] - Short-term borrowings rose to CNY 552,323,333.33 from CNY 300,220,000.00, indicating an increase of approximately 83.83%[17] - The company received 250,000,000.00 CNY in borrowings, a significant increase from 81,956,010.80 CNY in the previous period[26] - The cash outflow for debt repayment was 250,000,000.00 CNY, compared to 53,162,319.11 CNY in the previous period[26] Accounting Standards - The company did not apply new accounting standards or interpretations for the current year[26]